As promised, HDBuzz's Jeff Carroll finally signed up for the Enroll-HD study. Learn more about this important global HD "observational study" here.
Deutetrabenazine becomes the first new drug in a decade licensed by the FDA for symptoms of Huntington's disease
HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD
New technology enables researchers to find ultra-rare mutations in the HD gene, distinct from the one causing HD
A new scientific paper & lots of headlines about deutetrabenazine, a twist on treating chorea in Huntington's disease
A new population study reveals that relatively mild forms of the HD mutation are much more common than we thought
Sleep deficits precede motor problems in HD
Phase 2/3 clinical trial results prove inconclusive for Huntington's drug cysteamine.
Companions of HD gene carriers are more likely to notice psychological changes in presymptomatic HD.